Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: a systematic review and meta-analysis
- PMID: 40099004
- PMCID: PMC11911704
- DOI: 10.1136/bmjonc-2024-000633
Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: a systematic review and meta-analysis
Abstract
Objective: The aim of this study was to determine the impact of margin width and boost radiotherapy on the local recurrence risk of pure ductal carcinoma in situ (DCIS).
Methods and analysis: This is a prospectively registered systematic review and meta-analysis reporting relative risk (RR), OR and HR margin width outcomes. Eligible studies included prospective and retrospective case series with defining margin widths and 48 months of minimum follow-up. All patients (100%) received adjuvant whole breast radiotherapy (WBRT).
Results: A total of 40 265 patients with pure DCIS in 31 studies were included. ORs and RR were calculated from 15 studies in 12 519 patients, and HRs were calculated from 12 studies in 12 946 patients. Local recurrence was significantly greater with narrower 'close' margins; 0.1-1 mm versus >1 mm in RR (2.88, 95% CI 1.86 to 3.90; p<0.05), OR (4.82, 95% CI 2.45 to 9.48; p<0.05) and HR analysis (1.34, 95% CI 1.01 to 1.67; p<0.05). Compared with margins >2 mm, significantly greater local recurrence was observed in margins 0.1-2 mm in RR (1.72, 95% CI 1.09 to 2.35; p<0.05) and OR (4.43, 95% CI 3.02 to 6.50; p<0.05). Comparing 0.1-1 mm versus >1 mm and 0.1-2 mm versus >2 mm, differences in local recurrence were not statistically significant, once adjusted for boost radiotherapy.
Conclusions: In pure DCIS with WBRT, the local recurrence risk reduces as margin width increases up to 2 mm. The strength of the recommendation for a minimum clear margin of 2 mm is limited by a lack of data comparing 1.1-2 mm with >2 mm. The association between recurrence and close margins is not significant following boost radiotherapy, suggesting a possible alternative to re-excision in patients with close margins <2 mm.
Systematic review registration: CRD42022308524.
Keywords: Breast cancer (female); Radiation oncology.
Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
RIC declares institutional research funding from SECA and Astra-Zeneca which do not relate to this original research. HA is Chief Scientific Officer, Preemptive Health and Medicine, Flagship Pioneering who does not relate to this original research. The remaining authors declare no conflict of interest.
Figures




Comment in
-
Critical appraisal of the 2 mm threshold in ductal carcinoma in situ: methodological concerns in meta-analysis of margin width and local recurrence risk.Gland Surg. 2025 Apr 30;14(4):771-775. doi: 10.21037/gs-2025-108. Epub 2025 Apr 25. Gland Surg. 2025. PMID: 40405944 Free PMC article. No abstract available.
References
-
- American Cancer Society Cancer facts and figures 2024. [2-Dec-2024]. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... Available. Accessed.
-
- Cancer Research UK Ductal carcinoma in situ (DCIS) 2023. [10-Dec-2024]. https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/ductal... Available. Accessed.
-
- Netherlands comprehensive cancer organisation (iknl) 2023. [10-Dec-2024]. https://nkr-cijfers.iknl.nl/viewer/incidentie-per-jaar?language=en_GB&vi... Available. Accessed.
LinkOut - more resources
Full Text Sources